Surgery

Early tracheostomy no aid for severe stroke outcomes

Early tracheostomy does not significantly improve the rate of survival without severe disability at six months for patients with severe stroke receiving mechanical ventilation, according to a study published online May 4 ...

Medications

Subcutaneous mAb may benefit high-risk outpatients with COVID-19

For high-risk outpatients with mild-to-moderate COVID-19, subcutaneously administered monoclonal antibody (mAb) treatment with casirivimab and imdevimab is associated with reduced risk for 28-day hospitalization or death ...

Medical research

Ivermectin does not prevent progression to severe COVID-19

Ivermectin treatment during early illness does not prevent progression to severe disease for high-risk patients with mild-to-moderate COVID-19, according to a study published online Feb. 18 in JAMA Internal Medicine.

page 7 from 33